Therapy with amlodipine besylate/benazepril HCl provides superior control in patients with severe systolic hypertension.

被引:0
|
作者
Nwose, O [1 ]
Jean-Louis, L [1 ]
Schofield, L [1 ]
Purkayastha, D [1 ]
Baron, M [1 ]
机构
[1] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 43卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
84
引用
收藏
页码:1034 / 1034
页数:1
相关论文
共 50 条
  • [31] Initial combination therapy with aliskiren and hydrochlorothiazide is more effective than amlodipine in patients with stage 2 systolic hypertension and diabetes mellitus
    Townsend, R. R.
    Forker, A.
    Rumpelt, P.
    Papst, C. Cherif
    Yadao, A.
    DIABETOLOGIA, 2010, 53
  • [32] Comparison of Aliskiren/Hydrochlorothiazide Combination Therapy and Amlodipine Monotherapy in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
    Townsend, Raymond R.
    Forker, Alan D.
    Bhosekar, Vaishali
    Yadao, Anthony
    Keefe, Deborah L.
    JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (12): : 889 - 897
  • [33] Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension (vol 6, 96, 2020)
    Zhang, Lei-Ke
    Sun, Yuan
    Zeng, Haolong
    Wang, Qingxing
    Jiang, Xiaming
    Shang, Wei-Juan
    Wu, Yan
    Li, Shufen
    Zhang, Yu-Lan
    Hao, Zhao-Nian
    Chen, Hongbo
    Jin, Runming
    Liu, Wei
    Li, Hao
    Peng, Ke
    Xiao, Gengfu
    CELL DISCOVERY, 2021, 7 (01)
  • [34] TRIPLE COMBINATION OF VALSARTAN, AMLODIPINE, AND HCTZ PROVIDES EFFECTIVE REDUCTION OF BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION NOT CONTROLLED BY DUAL THERAPY WITH AMLODIPINE PLUS VALSARTAN OR VALSARTAN PLUS HCTZ
    Braun, N.
    Handrock, R.
    Klebs, S.
    Schweizer, J.
    JOURNAL OF HYPERTENSION, 2009, 27 : S272 - S273
  • [35] SWITCH TO A FIXED-DOSE COMBINATION THERAPY WITH TELMISARTAN AND AMLODIPINE PROVIDES SIGNIFICANT BLOOD PRESSURE REDUCTION AND CONTROL IN PATIENTS NOT ADEQUATELY CONTROLLED WITH AMLODIPINE 10 MG
    Neldam, S.
    Edwards, C.
    JOURNAL OF HYPERTENSION, 2009, 27 : S277 - S277
  • [36] Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension
    DE Hilleman
    AP Reyes
    RL Wurdeman
    M Faulkner
    Journal of Human Hypertension, 2001, 15 : 559 - 565
  • [37] Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension
    Hilleman, DE
    Reyes, AP
    Wurdeman, RL
    Faulkner, M
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (08) : 559 - 565
  • [38] Bisoprolol/amlodipine combination therapy improves blood pressure control in patients with essential hypertension following monotherapy failure
    Gottwald-Hostalek, Ulrike
    Li, Lion
    Montenegro, Pablo
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (10) : 1735 - 1743
  • [39] Initial combination therapy with olmesartan/hydrochlorothiazide shows superior blood pressure control rate in moderate to severe hypertension
    Rump, LC
    Ambrosioni, E
    Burnier, M
    Hörl, W
    Rabelink, AJ
    JOURNAL OF HYPERTENSION, 2004, 22 : S381 - S382
  • [40] OLMESARTAN MEDOXOMIL/AMLODIPINE (OLM/AML) PROVIDES 24-HOUR ANTIHYPERTENSIVE EFFICACY - ADDITIONAL EFFECT BY UPTITRATION IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSION
    Heagerty, A. M.
    Laeis, P.
    Haag, U.
    JOURNAL OF HYPERTENSION, 2009, 27 : S283 - S283